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To date, radiotherapy remains one of the most effective anticancer
treatments. Its efficiency relies on the physical targeting of the
tumour mass and for some types of lymphomas on the induction of
apoptosis into the malignant cells by ionizing radiation (IR)
(Zhivotovsky et al, 1999). However, despite the steadily increasing
knowledge in our understanding of apoptosis, its triggering by IR
still remains elusive and could involve DNA damage, membrane
alterations, ceramide formation (Haimovitz-Friedman et al, 1994),
reactive oxygenated species generation (Buttke and Sandstrom,
1994), up-regulation of CD95/Fas/APO-1 (Belka et al, 1998) and
caspases activation (Hallan et al, 1997), including caspase-3 (Datta
et al, 1997). In the last few years, it has become clear that the
caspases network is a central actor of the apoptotic machinery.
Indeed, these cysteine proteases are involved in the early phases of
apoptosis: induction and transduction of the death signal, as well as
in the final step: the execution phase. The number and the functional
importance of their substrates in the cell cycle regulation, DNA
repair, cytoskeleton and nuclear lamina suggest that caspase
activation leads to cell demise (Cohen, 1997). Thus, modifying the
activity of one of these proteases could constitute a fruitful approach
for the modulation of the apoptotic process and possibly other types
of cell death (Mignon et al, 1998; Thornberry and Lazebnik, 1998).
While in several studies it has been reported that in fact, caspase
inhibition prevents apoptotic hallmarks, some recent works also
showed that the inhibition of caspases does not affect cell survival
but shifts cell death from apoptosis to necrosis, suggesting the
existence of a common initial pathway between these two forms 
of cell death (Hirsch et al, 1997; Lemaire et al, 1997).
Although necrosis and the subsequent inflammation should be
avoided in morphogenesis, immune regulation or tissue homeo-
stasis, its occurrence might be of interest in anticancer treatment
since it could enhance the recruitment of macrophages and T cells
which in turn could participate to the eradication of tumour cells
(Reiter et al, 1999). Necrotic cell death was also found to activate
and mature dendritic cells (Sauter et al, 2000). Moreover, necrotic
cells, by spreading out their intracellular content including active
enzymes and reactive oxygenated species, could also damage
surrounding cells.
Recently, characterization of the cleavage site of some caspase
substrates gave rise to specific oligopeptide inhibitors, such as Ac-
DEVD-CHO, a competitive and reversible inhibitor of caspase-3-
like enzymes (Nicholson et al, 1995). By using this tetrapeptide, we
have investigated whether the inhibition of caspase-3-like activity
could influence the morphological and biochemical features of radi-
ation-induced apoptosis in the human leukaemic cell line MOLT-4.
Cells were pretreated with Ac-DEVD-CHO (300 µ M) and
submitted to X-rays at doses ranging from 1 y to 4 Gy. Our results
show that the inhibition of caspase-3-like proteases prevented the
appearance of hallmarks of apoptosis such as internucleosomal
DNA fragmentation or hypodiploid particle formation.
Phosphatidylserine externalization was partially inhibited by Ac-
DEVD-CHO, suggesting that caspase-3-like enzymes are involved
in this apoptotic feature. Although inhibition of DEVD-specific
proteases could prevent apoptosis, no persistent increase in cell
survival nor clonogenic potential was recorded. Moreover, irradi-
ated cells treated by this caspase-3 inhibitor exhibited characteristics
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The two first authors contributed equally to this study.of a necrotic cell death. These results not only indicate that caspase-
3 is a central protease in the execution of the apoptotic process, but
that its inhibition could also orient cell death toward necrosis.
MATERIALS AND METHODS
Chemicals
Trypan blue, EDTA, EGTA, Tris, DTT, CHAPS, HEPES, NaCl,
MgCl2 and propidium iodide were purchased from Sigma Chemical
Co (St Louis, MO). The inhibitor Ac-DEVD-CHO and the colori-
metric substrate Ac-DEVD-pNA of caspase-3-related proteases
were obtained from Neosystem (Strasbourg, France). Leupeptin,
pepstatin, aprotinin, PMSF, bovine serum albumin (BSA) and
RNase A, DNase free were purchased from Boehringer Mannheim
Corp (Indianapolis, IN). Triton X-100 and Tween 20 were
purchased from Calbiochem-Novabiochem Corp (San Diego, CA).
Cell culture
Cells were grown in suspension in RPMI 1640-Glutamax (Life
Technologies, Inc, Gaithersburg, MD) supplemented with 10%
heat inactivated fetal calf serum (DAP, Vogelgrün, France), 
1 mM sodium pyruvate, 1 mM non-essential aminoacids and 
50 µ g/ml gentamycin (Life Technologies, Inc). They were main-
tained at 37° C in a humidified atmosphere containing 5% CO2.
Cells were harvested during exponential growth and mortality
never exceeded 5% as assessed by Trypan blue exclusion test.
Irradiation procedure
Cells in exponential phase of growth were harvested by centrifuga-
tion and brought to 106 cells/ml in fresh medium. Cells were
irradiated at room temperature by an X-ray linear accelerator of 
15 MV (Centre Paul Strauss, Strasbourg, France) at a dose rate of
approximately 2.50 Gy/min.
DNA labelling and flow cytometry analysis
Hypodiploid DNA was measured as described in previous work
(Nicoletti et al, 1991). Briefly, 106 cells were centrifuged and fixed
in 1 ml cold 70% ethanol at 4° C for one hour, washed once in PBS
(Life Technologies), EDTA 2 mM, and resuspended in 1 ml of
PBS containing 0.25 mg Rnase A, EDTA 2 mM and 0.1 mg of
propidium iodide. After incubation in the dark at 37° C for 30 min,
cells were kept at 4° C for less than 12 hours until analysis. The
fluorescence of 10 000 cells was analysed using a flow cytometer
(FACScan, Becton Dickinson, San Jose, CA).
Annexin V-FITC and propidium iodide simultaneous
staining
Phosphatidylserine externalization was assessed by measuring
annexin V-FITC binding using a kit from Euromedex
(Souffelweyersheim, France) and according to the manufacturer’s
instructions. Briefly, cells were washed in cold RPMI and for each
sample 5 × 105 cells were resuspended in 100 µ l of the reaction
buffer (10 µ l of binding buffer 10 × , 10 µ l of propidium iodide, 1 µ l
of annexin V-FITC and 79 µ l of deionized water). After 15 min of
incubation in the dark at room temperature, each reaction was
diluted with binding buffer 1 × to obtain a final volume appropriate
for flow cytometry (at least 200 µ l). Samples were then immedi-
ately analysed using a flow cytometer (Becton Dickinson).
Western blot
2 × 106 cells were lysed for 20 min at 4° C in lysis-buffer (Tris HCl
50 mM pH 7.5, MgCl2 8 mM, EDTA 5 mM, EGTA 0.5 mM,
leupeptin 10 µ g/ml, pepstatin 10 µ g/ml, aprotinin 10 µ g/ml, PMSF
1 mM, NaCl 250 mM, Triton X-100 1%). Protein content was
assessed using BCA protein assay (Pierce, Rockford, IL). Equal
amounts of protein were submitted to a 12% SDS-polyacrylamide
gel electrophoresis at 100 V for 90 min. Proteins were then elec-
trophoretically transferred onto a nitrocellulose membrane (Pall
Gelman Sciences, Ann Arbor, MI). Membranes were incubated in
blocking buffer (Tris HCl 7.5 pH 10 mM, NaCl 100 mM, Tween
20 0.1%, bovine serum albumin 3%) for 60 min at 37° C, and then
incubated with mouse monoclonal antibody antihuman
CPP32/Casp-3, mouse monoclonal antibody antihuman Casp-7
(1/10 000 dilution, Transduction Laboratories, Lexington, KY) or
mouse anti-actin monoclonal antibody (Chemicon International,
Inc, Temecula, CA). Membranes were washed twice (Tris HCl 7.5
pH 10 mM, NaCl 100 mM, Tween 20 0.1%), reblocked in BSA-
containing buffer, incubated with peroxydase-conjugated goat
anti-mouse antibody (1/50 000 dilution, Jackson ImmunoResearch
Laboratories, Inc, West Grove, PA) and washed twice in TBS
buffer. Immunoblots were visualized by Opti 4CN (Bio-Rad
Laboratories, Hercules, CA). Intensity of bands was measured
using NIH Image software.
Catalytic activity
2 × 107 cells were washed twice in PBS containing EDTA 2 mM
and incubated in lysis buffer (HEPES 50 mM, pH 7.4, CHAPS
0,1%, DTT 1 mM, EDTA 0.1 mM) on ice for 20 min. Lysates were
centrifuged at 10 000 g at 4° C during 10 min and supernatants
were stored at –70° C until analysis. 20 µ l of each supernatant were
then incubated with 10 µ l of Ac-DEVD-pNA (200 µ M) and 70 µ l
of assay buffer (HEPES 50 mM, pH 7.4, NaCl 100 mM, CHAPS
0,1%, DTT 10 mM, EDTA 1 mM, glycerol 10%) at 37° C during 1
hour. Samples were read at 405 nm.
TUNEL assay
107 cells were washed once in PBS and fixed in a 4%
paraformaldehyde solution at 4° C during 20 min. Cells were then
washed in PBS, incubated 20 min at 4° C in a 70% methanol solu-
tion containing 0.3% H2O2, washed in PBS, incubated 2 min at
4° C in 2% Triton, washed in PBS, incubated 80 min at 37° C in a
terminal deoxynucleotidyl transferase working buffer (Boehringer
Mannheim), washed in PBS and analysed by flow cytometry.
LDH release
Cell lysis was assessed by measuring LDH release using a
Cytotoxicity Detection kit from Boehringer Mannheim according
to the manufacturer’s instructions. Samples were read at 490 nm
on a microplate MRX reader (Dynex Technologies, Issy-les-
Moulineaux, France) and results were expressed as follows: 100 ×
LDH in supernatants (cytoplasmic LDH+LDH in supernatants).
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After X-irradiation, cells were washed with RPMI 1640 and
seeded in triplicate in a petri-dish at a concentration of 300
cells/dish in a plasma medium containing human AB serum 20%
(Etablissement de Transfusion Sanguine de Strasbourg, France),
BSA 10%, RPMI 1640 50%, plasma bovine citrate 10% (Life
Technologies), CaCl2 and asparagine 10%, and were allowed to
grow for 14 days at 37° C in a humidified atmosphere containing
5% CO2. Cell-forming colonies number was determined at each 
X-ray dose.
Alamar blue proliferation test
This assay was performed according to manufacturer’s instruc-
tions (Alamar, Sacramento, CA). Briefly, after X-irradiation cells
were seeded at 5000 cells/well (200 µ l) in a 96-wells microplate.
Each experimental assay was performed in triplicate. After 4 days
of incubation, supernatants were replaced with fresh culture
medium and 20 µ l of Alamar Blue working solution was added to
each well. After incubation at 37° C in a humidified atmosphere
containing 5% CO2, during 4 hours, plates were read at 590 nm
(excitation: 560 nm) on a microplate Flow Multiscan reader
(Dynex Technologies).
RESULTS
Irradiation of MOLT-4 cells induces caspase-3-like
activity blocked by Ac-DEVD-CHO
We first examined the involvement of caspase-3-like activity in both
spontaneous and X-rays-induced apoptosis using Ac-DEVD-pNA,
a colorimetric substrate that mimics the cleavage site of caspase-3-
like proteases endogenous substrate PARP (Gurtu et al, 1997).
MOLT-4 cells were pretreated with a reversible and potent
inhibitor of the caspase-3-like activity, Ac-DEVD-CHO (300
µ M), 1 hour prior to 2 Gy irradiation. Ac-DEVD-pNA cleaving
activity was then measured after 6, 12 and 24 hours of culture.
This colorimetric assay shows that a pronounced increase of the
DEVD-specific activity occurs 12 hours after irradiation in
untreated MOLT-4 cells (Figure 1A) and culminates at 24 hours. In
the presence of the inhibitor, no significant DEVDase activity was
recorded throughout the culture time. Our results confirm that
caspase-3-like proteases are activated following ionizing radiation
(Datta et al, 1997; Hallan et al, 1997; Machleidt et al, 1998).
Caspase-3-like activity induced by irradiation involves
caspase-3 and caspase-7
The proteolytic activity detected using Ac-DEVD-pNA could be
due to caspase-3 but also to another protease such as caspase-7
(Thornberry et al, 1997). These cysteine proteases are expressed in
cells as inactive zymogens and converted during the apoptotic
process in their active forms by proteolytic processing after a
specific aspartate residue. Inactive caspase-3 is a 32 kDa proform
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Figure 1 Activation of caspase-3-like proteases by ionizing radiation. (A) MOLT-4 cells were cultured for 24 hours following 2 Gy X-irradiation. At the indicated
times, cells were washed, lysed and hydrolysis of Ac-DEVD-pNA was measured at 405 nm as described in Materials and Methods. The fold increase in DEVD-
pNA cleaving activity was calculated by comparing the percentage of enzymatic activity in control cells versus the percentage of enzymatic activity in cells
treated with Ac-DEVD-CHO. Each point represents a mean of three independent experiments in duplicate ± SD. (B) Western blot analysis of caspase-3,
caspase-7 and actin. At the indicated times, 50 µ g of proteins per lane, isolated from cell lysates were submitted to 12% SDS-PAGE. Values of intensity were
calculated using NIH Image software. (C) Western blot analysis of procaspase-3 in cells cultured in presence of Ac-DEVD-CHO, 24 hours after irradiation at 2
Gy. The 20 kDa band is an intermediate form of the full processing of procaspase-3. Immunodetection of caspase-3 and caspase-7 were performed with mouse
monoclonal anti-CPP32 antibody and mouse monoclonal anti-MCH3 antibody respectively and Opti 4CN assay. The antibodies used do not recognize the
active subunits of the respective caspases. All immunoblots were performed with equal amount of proteins in each lanewhich is enzymatically processed into a 12 kDa subunit, a 20 kDa
intermediate subunit and mature, active, 17 kDa subunit (Han et al,
1997). Although the processing of caspase-7 is less well docu-
mented, its proform (35 kDa) is also cleaved to give rise to two
subunits of 11 kDa and 19 kDa (Fernandes-Alnemri et al, 1997).
To define the contribution of caspase-3 versus caspase-7 in the
proteolytic response induced by irradiation, we examined the
expression of both enzymes by Western blot analysis. Western blot
of actin was also performed and intensity of bands was measured
with NIH Image software. The data in Figure 1B show that non-
irradiated MOLT-4 cells express proforms of caspase-3 and
caspase-7 but no detectable levels of active subunits. The 32 kDa
procaspase-3 was down-regulated within 24 hours following an
irradiation at 2 Gy, suggesting that the zymogen form was
processed into its active subunits (Yu and Little, 1998). The 
35 kDa proform of caspase-7 was also down-regulated following
exposure to ionizing radiation in a time-dependent manner.
Consistent with previous data (Han et al, 1997), the inhibition of
caspase-3-like activity by Ac-DEVD-CHO treatment, prevented
the appearance of the mature 17 kDa subunit and induced the accu-
mulation of the 20 kDa intermediate (Figure 1C). Interestingly, the
down-regulation of the caspase-7 zymogen seems to appear earlier
Caspase-3-like activity in MOLT-4 leukaemia cells 645
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Figure 2 Inhibition of apoptotic hallmarks by Ac-DEVD-CHO. (A) Incorporation of dUTP-FITC (TUNEL), measured by flow cytometry, 24 hours after X-
irradiation within a range of 1 to 4 Gy. (B) Flow cytometry analysis quantifying hypodiploid particles with subG0–G1 DNA content, excluding cellular debris, after
X-irradiation at 2 Gy. At the indicated times, cells were washed, fixed and labelled with propidium iodide as described in Materials and Methods. (C) Kinetics of
phosphatidylserine externalization with or without Ac-DEVD-CHO treatment after X-irradiation at 2 Gy. At the indicated times, cells were simultaneously stained
with propidium iodide and annexine V-FITC conjugate which detect specifically exposure of phosphatidylserine on the outer leaflet of the plasma membrane and
analysed by flow cytometry. (D) Dot-plot representation of the simultaneous staining, 12 hours after irradiation at 2 Gy. All results are representative of three
independent experiments.than caspase-3 processing, suggesting that caspase-7 activity
could act upstream of caspase-3. Thus, our results confirm that
Ac-DEVD-CHO inhibits caspase-3-like activity not only by
competition with endogenous substrates but also by the prevention
of caspase-3 activation. These findings indicate that ionizing radi-
ation activate both caspase-3 and caspase-7 in MOLT-4 cells.
DNA fragmentation and hypodiploid particles induced
by irradiation are prevented by Ac-DEVD-CHO
One of the most common hallmarks of the apoptotic cell is DNA
fragmentation. Therefore we analysed DNA content of MOLT-4
cells by the TUNEL assay adapted to flow cytometry, 24 hours
after irradiation (Figure 2A). Our results show that DNA frag-
mentation induced by ionizing radiation is dose-dependent and
culminate in 41% of TUNEL-positive cells 24 hours after 4 Gy
irradiation. Apoptosis was also assessed by propidium iodide
labelling and flow cytometry analysis of irradiated MOLT-4 cells.
As DNA fragmentation, hypodiploid particles formation was
found to be dose-dependent following ionizing irradiation within
a range of 1 to 4 Gy (Figure 2B). To determine if caspase-3-like
proteases play a role in apoptotic DNA fragmentation, we
pretreated MOLT-4 cells with Ac-DEVD-CHO (300 µ M) 1 hour
before irradiation within a range of 1 to 4 Gy. As shown in Figure
2A, inhibition of caspase-3-like proteases prevented quite
completely DNA fragmentation, at both 2 and 4 Gy. The number
of TUNEL-positive cells, 24 hours after irradiation at 4 Gy,
decreased from 41% to 8%, and from 22% to 8% at 2 Gy,
indicating that DEVD-inhibitable proteases are necessary to
radiation-induced DNA fragmentation. As shown in Figure 2B,
pretreatment of the cells with Ac-DEVD-CHO resulted in a
marked decrease of hypodiploid particles formation, not only due
to the prevention of DNA fragmentation, as assessed by the
TUNEL method, but also to a slight decrease of membrane
blebbing (data not shown).
Irradiation induces phosphatidylserine externalization
which is partially inhibited by Ac-DEVD-CHO
Externalization of phosphatidylserine, usually located in the inner
leaflet of the plasma membrane, is one of the earliest manifesta-
tions of apoptosis, preceding DNA fragmentation and membrane
blebbing (Verhoven et al, 1995). The mechanisms responsible for
this asymmetry, for its preservation and for its loss remain elusive
but presumably involve the activation of a non-specific scram-
blase and the inhibition of a specific translocase (Zwaal and
Schroit, 1997). Thus, we used annexin V-FITC conjugate to
detect phosphatidylserine exposure on the outer leaflet of the
plasma membrane. Consistent with previous reports (Martin et al,
1996), Ac-DEVD-CHO partially prevented phosphatidylserine
redistribution of the apoptotic cells (Figure 2C). The number of
annexin V-positive cells, 24 hours after 2 Gy irradiation, was 64%
in non-treated cells and 36% in Ac-DEVD-CHO treated cells,
suggesting that the mechanisms responsible for phosphatidyl-
serine externalization are partially sensitive to DEVDase activity,
or that other molecular mechanisms are involved in apoptotic
feature. Interestingly, the propidium iodide versus annexin V-
FITC staining pattern shows an obvious difference between the
cells cultured in the absence or in the presence of the caspase
inhibitor (Figure 2D).
Ac-DEVD-CHO does not prevent cell death induced by
irradiation but causes necrotic death
The above mentioned data established that Ac-DEVD-CHO
inhibits caspase-3-like activity and the emergence of features of
apoptosis in irradiated MOLT-4 cells. Next, it was important to
determine whether this compound would affect the occurrence of
cell death in our model. This was evaluated using several parame-
ters. As expected, irradiation of MOLT-4 cells caused a dose-
dependent decrease in cell survival, reflected by reduced Trypan
blue exclusion (Figure 3A), Alamar blue uptake (Figure 3B) and
clonogenic potential. In fact, such a treatment resulted in a marked
increase of necrotic death, as assessed by lactate dehydrogenase
(LDH) release (Figure 3D) and by morphological criteria (data 
not shown). The increased release of LDH clearly demonstrates
the occurrence of necrosis, since LDH release implies strong
mitochondrial alteration and plasma membrane disruption.
Furthermore, the simultaneous staining with propidium iodide and
annexin V-FITC (Figure 2D) showed an apoptotic population in
the irradiated cells (annexin V positive and propidium iodide
negative) which was absent in the irradiated cells cultured with the
caspase inhibitor. In this case the cells were equally positive on
both stainings, suggesting that the slight increase of annexin V-
positive cells was due to the loss of membrane integrity associated
with necrosis rather than to the phosphatidylserine externalization
associated with apoptosis. These data clearly demonstrate that co-
treatment with Ac-DEVD-CHO reduced apoptosis due to ionizing
radiation but did not affect the percentage of dead cells. Thus,
following ionizing irradiation of MOLT-4 cells, if caspase-3-like
activity is blocked, apoptosis to necrosis conversion occurs.
DISCUSSION
In the present study, we have investigated the involvement of the
caspase-3 functional subfamily in apoptosis induced by ionizing
radiation and the cellular consequences of its inhibition by the
reversible inhibitor Ac-DEVD-CHO (Nicholson et al, 1995;
Hallan et al, 1997). This compound prevented internucleosomal
DNA fragmentation and hypodiploid particle formation, indi-
cating that the induction of such apoptotic features is dependent on
caspase-3 like activity. However, Ac-DEVD-CHO inhibited only
partially the externalization of phosphatidylserine, an observation
consistent with earlier studies (Martin et al, 1996). In fact, it seems
likely that phosphatidylserine redistribution is not due to the
activity of caspase-3 itself but rather to that of another DEVD-
sensitive protease since this response could be recorded in
caspase-3–/– thymocytes following Fas-L ligation (Zheng et al,
1998). Here we show that MOLT-4 cells express caspase-7, an
effector caspase with the same functional specificities as caspase-
3 (Fernandes-Alnemri et al, 1995; Thornberry et al, 1995).
Furthermore, down-regulation of procaspase-7 suggests that
caspase-7 is activated following exposure of MOLT-4 cells to
ionizing radiation (Figure 1B). It is therefore possible that caspase-
7 represents the putative DEVD-sensitive protease distinct from
caspase-3, which contributes to phosphatidylserine redistribution,
both after Fas-L ligation (Martin et al, 1996) and irradiation.
Further work will be required to test this hypothesis. In any case,
our data are in keeping with the general notion that caspase-3-like
proteases are crucially involved in most of the nuclear and cyto-
plasmic alterations associated with the apoptotic process (Zheng 
et al, 1998).
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bition of caspase-3-like proteases does not affect cell survival of
irradiated MOLT-4 cells but leads the initiated apoptotic process
towards a necrotic death. In fact, the data imply that radiation can
kill by different mechanisms, depending on the enzymology of the
cell. Such a switch from apoptosis to necrosis had already been
described in B-lymphocytes and thymocytes treated with apop-
tosis-inducing drugs (Hirsch et al, 1997; Lemaire et al, 1998), in
HL-60 cells treated with oxidized low density lipoproteins
(Richter et al, 1996) and in camptothecin-treated U937 cells (Sané
and Bertrand, 1999). Our experiments provide the first evidence
that this phenomenon also occurs in the context of irradiation.
Furthermore, while the previous studies utilised Z-VAD-fmk, a
broad spectrum inhibitor of caspases (Hirsch et al, 1997; Lemaire
et al, 1998; Sané and Bertrand, 1999), or modulation of Bcl-2
levels (Richter et al, 1996), we took advantage of the more
restricted selectivity of Ac-DEVD-CHO to clearly demonstrate the
role of the caspase-3 subfamily in this switch. In contrast with
recent work showing that inhibition of caspases with a crmA
variant, namely crmA DQMD, could enhance clonogenic survival
in response to ionizing radiation in the WEHI-7 murine T
lymphoblast cell line, another crmA variant, crmA DEVD, also
failed to protect irradiated cells (Stefanelli et al, 1997). Thus, our
results are in agreement with these data and confirm that inhibition
of DEVD-sensitive caspases activity does not rescue cells from
radiation-induced apoptosis but is responsible for the switch from
apoptosis to necrosis. Further experiments will be required to
compare the efficiency and the specificity of a DQMD-based
tetrapeptide inhibitor to Ac-DEVD-CHO.
At the moment, the possible mechanism of the apoptosis to
necrosis conversion recorded here and in other studies remains
unclear. The formation of the apoptosome has been found to
require ATP (Li et al, 1997). Therefore, ATP depletion might inter-
fere with the initiation of the caspase cascade at this level (Eguchi
et al, 1997; Leist et al, 1997). Thus, impeding the activation of
effector caspases by ATP depleted conditions or inhibiting their
Caspase-3-like activity in MOLT-4 leukaemia cells 647
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Figure 3 Inhibition of caspase-3-like enzymes has no effect on cell viability, nor clonogenic potential and orients cell death toward necrosis. (A) Cell viability
was determined 24 hours after X-irradiation within a range from 0.5 to 4 Gy. Reported are mean values of three independent experiments in duplicates ± SD.
(B) Determination of cell viability by the Alamar blue proliferation assay. Alamar blue assay was performed according to the manufacturer’s instructions. Briefly,
5000 cells were cultured during 4 days after X-irradiation within a range from 1 to 4 Gy. SD are, in all cases, < 10%. (C) Determination of the cell-surviving
fraction, determined after 14 days of culture. Each point represents a mean of three independent experiments in triplicates ± SD. (D) The percentage of necrotic
cells was determined by measuring LDH release 24 hours after X-irradiation within a range from 1 to 4 Gy in the absence and in the presence of Ac-DEVD-CHO
(300 µ M). Each point represents a mean of three independent experiments in duplicates ± SD.activity with a synthetic tetrapeptide like Ac-DEVD-CHO would
only make necrosis obvious, despite the prevention of apoptosis
(McCarthy et al, 1997). Furthermore, it has been recently
demonstrated that the failure of PARP cleavage by caspases, in
fibroblasts expressing caspase-resistant PARP, could lead to the
induction of necrosis (Ha and Snyder, 1999; Herceg and Wang,
1999). It will be, therefore, of interest, in future experiments, to
measure intracellular ATP level in our experimental system and to
assess the exact role of caspases and PARP in its regulation.
Our data may favour a model whereby apoptosis and necrosis
share common initial events, presumably mitochondrial alter-
ations, the final fate of dying cells depending on the availability of
caspases acting downstream from mitochondria. We identified
caspase-3-like activity as the most likely post-mitochondrial step
that determines the choice between apoptosis and necrosis. The
rise of DEVD-sensitive activity and the processing of caspase-3
significantly occurred only 12 hours after irradiation (Figure 1).
Moreover, there was no difference in viability nor clonogenic
potential whether the cells were pretreated with the caspase
inhibitor 2 hours before or after the irradiation (data not shown).
This suggests that caspases are not directly activated by ionizing
radiation but could depend on upstream protease activity,
including the mitochondrial amplification step. At least two
DEVD-sensitive proteases, caspase-3 and caspase-7 seem to be
activated upon exposure of MOLT-4 cells to ionizing radiation.
Unlike caspase-3, active caspase-7 has been found exclusively in the
mitochondrial fractions of Fas-treated hepatocytes (Chandler et al,
1998), although the full processing of procaspase-3 depends on
upstream DEVDase activity (Han et al, 1997). Our results show that
full processing of caspase-3 is prevented by the inhibition of
DEVD-inhibitable proteases and that down-regulation of procas-
pase-7 takes place early after irradiation and in a time-dependent
manner. Hence, it is tempting to speculate that caspase-7 might be
first activated, after formation of the mitochondrial apoptosome, and
would then subsequently participate in the processing of caspase-3.
The large body of experimental evidence so far accumulated has
led to a fundamental distinction between apoptosis and necrosis
based on the activation of caspases (Hirsch et al, 1997).
Nonetheless, our study supports the recent idea that these two
types of cell death are less distinctly separated than implied by 
the apparent morphological and functional dichotomy. Beyond
considerations about the differences between an incomplete apop-
tosis and a necrotic death, the therapeutic potential of such a cell
death conversion should be pointed out in anticancer treatment
(Melcher et al, 1999; Reiter et al, 1999). Unlike chemotherapy,
radiotherapy allows for a precise physical targeting of the tumour
mass. The conjunction of radiotherapy with treatment by an
inhibitor of caspase-3-like proteases might then be able to induce
necrosis, rather than apoptosis within the tumour mass, sparing
normal tissue. One might envision that necrosis and the subse-
quent localized inflammation would facilitate the eradication of
malignant cells by enhancing the recruitment of immune cells
within the tumour and by propagating damage to bystander tumour
cells (McConkey, 1998; Reiter et al, 1999). Further in vivo experi-
ments appear justified to examine the validity of this concept.
ABBREVIATIONS
Ac-DEVD-CHO, acetyl-Asp-Glu-Val-Asp-aldehyde; Ac-DEVD-
pNA, acetyl-Asp-Glu-Val-Asp-paranitroaniline; LDH, lactate
dehydrogenase; PARP, poly(ADP-ribose) polymerase; CHAPS, 3-
((3-cholamidopropyl)dimethylammonio)-1-propanesulphonate;
DTT, dithiothreitol; EGTA, egtazic acid; PMSF, phenylmethyl-
sulphonylfluoride; HEPES, N-(2-hydroxyethyl)piperazine-N’-(2-
ethanesulphonic acid).
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